Rafael Amado - 01 May 2023 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role: Director
Signature: /s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 May 2023
Net transactions value: $0
Form type: 4
Filing time: 02 May 2023, 16:14:25 UTC
Previous filing: 14 Apr 2023
Next filing: 03 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PSTX	Common Stock	Award	$0	+39,300		$0.000000	39,300	01 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PSTX	Stock Option (Right to Buy)	Award	$0	+55,200		$0.000000	55,200	01 May 2023	Common Stock	55,200	$2.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares issuable upon the vesting of restricted stock units ("RSUs") granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in three successive equal annual installments following May 1, 2023.
F2	The stock option will vest and become exercisable in 36 equal monthly installments following May 1, 2023.